Abfero Limited

UK company 11255897, incorporated on 14 March 2018.

Abfero Pharmaceuticals | Iron as a Therapeutic Target

Our mission is to develop best-in-class, safe and effective oral iron chelators for the treatment of diseases of iron overload.

Company number

11255897

Incorporated

14 Mar 2018

Companies House status

Active

Company identity

Founded / incorporated

14 March 2018

Company number 11255897

Legal name

ABFERO LIMITED

Company type

LTD

Region

South East England

Registered address

Unknown

Insolvency history

Reference milestones and recent Companies House filing stream events.

1 event

14 Mar

2018

Inception

Company registered at Companies House

1 award

First funded

2020

Funded years

2020

Age at first award

2 years

2020 EU-Funded Lead participant

1 Nov 2020 to 31 Oct 2023

Awarded

£252,515

Total cost £420,858

EU-Funded